AMANDA GARVEY: Open Payments
NPI 1629758560 · HANOVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,259 in 128 payments from 22 companies in 2025. Trend: 2023 $181 · 2024 $1,010 · 2025 $2,259
Food & beverage: $2,259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $443 |
| Exact Sciences Corporation | 9 | $226 |
| PFIZER INC. | 15 | $224 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $173 |
| Novartis Pharmaceuticals Corporation | 7 | $167 |
| Novo Nordisk Inc | 9 | $140 |
| Lilly USA, LLC | 7 | $118 |
| Teva Pharmaceuticals USA, Inc. | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| Merck Sharp & Dohme LLC | 4 | $90 |
Products named: VRAYLAR, CAPLYTA, LEQVIO, Cologuard Collection Kit, UBRELVY, AUSTEDO XR, QULIPTA, MOUNJARO.
Industry payments across PA — which companies pay providers there.
